New Documents Trace Controversial Hepatitis B Birth-Dose Study's Shortcut to CDC Approval
TL;DR Summary
A Rolling Stone investigation shows that a $1.6 million birth-dose hepatitis B vaccine study in Guinea-Bissau was moved directly from the CDC director’s office to grants management, bypassing normal scientific review and ethical oversight, amid pressure from Kennedy allies and irregular ethics approvals, drawing WHO concern and congressional scrutiny as the project remains in limbo.
- New Documents Reveal a Controversial Vaccine Study’s Unusual Path to CDC Approval Rolling Stone
- Planned US-funded baby vaccine trial in Guinea-Bissau blasted by WHO BBC
- Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau World Health Organization (WHO)
- WHO criticizes CDC-funded vaccine study in Africa as unethical CIDRAP
- West African Nation Cancels Trump-Era Vaccine Research Study Fine Day 102.3
Reading Insights
Total Reads
1
Unique Readers
12
Time Saved
30 min
vs 30 min read
Condensed
99%
5,974 → 55 words
Want the full story? Read the original article
Read on Rolling Stone